Back to 
HBK INVESTMENTS L P
HBK INVESTMENTS L P
VRNA2 quarters
Position history for HBK INVESTMENTS L P's holdings in VERONA PHARMA PLC
As of its Q3 2025 13F, HBK Investments held 4,263,576 shares of VRNA (Verona Pharma), worth $455M. VRNA was 5.0% of HBK Investments' reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$455M
Total Shares Change
-4.3M
Quarter-by-Quarter History
Other major holders of VRNA: Janus Henderson Group Ltd., Pentwater Capital Management LP, BlackRock, Inc., FIL Ltd